Find Federal Grants
Making Health care Safer in Ambulatory Care Settings and Long Term Care Facilities (R18)
Agency for Health Care Research and Quality · PA-18-750
Examining Diversity, Recruitment and Retention in Aging Research (R24 Clinical Trial Not Allowed)
National Institutes of Health · PAR-18-749
Research Supplements to Promote Data Sharing in Cancer Epidemiology Studies (Admin Supp Clinical Trial Not Allowed)
National Institutes of Health · PA-18-748
Addressing the Challenges of the Opioid Epidemic in Minority Health and Health Disparities Research in the U.S. (R01 Clinical Trial Optional)
National Institutes of Health · PAR-18-747
Addressing the Challenges of the Opioid Epidemic in Minority Health and Health Disparities Research in the U.S. (R21 Clinical Trial Optional)
National Institutes of Health · PAR-18-745
Substance Abuse and Mental Health Services Adminis · SM-18-009
NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)
National Institutes of Health · PAR-18-746
Impact of Initial Influenza Exposure on Immunity in Infants (U01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-AI-18-010
Rural Utilities Service · RUS-18-01-DLT
Substance Abuse and Mental Health Services Adminis · SP-18-006
Mechanistic Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-AR-19-006
Mechanistic Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed)
National Institutes of Health · RFA-AR-19-007
Pilot and Feasibility Clinical Research Grants in Kidney Diseases (R21 Clinical Trial Optional)
National Institutes of Health · PAR-18-744
Pilot and Feasibility Clinical Research Grants in Urologic Disorders (R21 Clinical Trial Optional)
National Institutes of Health · PAR-18-743
Project AWARE - States
Substance Abuse and Mental Health Services Adminis · SM-18-006
Limited Competition: Building Infrastructure Leading to Diversity (BUILD) Initiative Phase II (U54 Clinical Trial Not Allowed)
National Institutes of Health · RFA-RM-18-006
Mechanisms Underlying the Contribution of Type 1 Diabetes Disease-associated Variants (R01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-DK-18-005
Revision Applications to National Cancer Institute (NCI)-supported P50 Awards to Include Research on the NCIs Provocative Questions (P50 Clinical Trial Optional)
National Institutes of Health · RFA-CA-18-024
Revision Applications to National Cancer Institute (NCI)-supported P01 Awards to Include Research on the NCIs Provocative Questions (P01 Clinical Trial Optional)
National Institutes of Health · RFA-CA-18-023
Exploring Epigenomic or Non-Coding RNA Regulation in the Development, Maintenance, or Treatment of Chronic Pain (R61/R33 Clinical Trial Optional)
National Institutes of Health · PAR-18-742